Showing results 20 to 39 of 44
< previous
next >
| Issue Date | Title | Author(s) |
| 2023 | Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma | Song, Yuqin; Zhou, Keshu; Yang, Shenmiao; Hu, Jianda; Zou, Dehui; Gao, Sujun; Pan, Ling; Wang, Tingyu; Yang, Haiyan; Zhang, Huilai; Zhou, Daobin; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lv, Fangfang; Huang, Haiwen; Fan, Xiaosi; Xu, Sheng; Zhu, Jun |
| 2012 | Influence of Bentonite Particles on Representative Gram Negative and Gram Positive Bacterial Deposition in Porous Media | Yang, Haiyan; Tong, Meiping; Kim, Hyunjung |
| 2012 | Influence of humic acid on the transport behavior of bacteria in quartz sand | Yang, Haiyan; Kim, Hyunjung; Tong, Meiping |
| 2013 | Influence of nutrient conditions on the transport of bacteria in saturated porous media | Han, Peng; Shen, Xiufang; Yang, Haiyan; Kim, Hyunjung; Tong, Meiping |
| 2014 | Influence of silicate on the transport of bacteria in quartz sand and iron mineral-coated sand | Dong, Zhe; Yang, Haiyan; Wu, Dan; Ni, Jinren; Kim, Hyunjung; Tong, Meiping |
| 2014 | Influence of sulfate and phosphate on the deposition of plasmid DNA on silica and alumina-coated surfaces | Min, Xiaopeng; Han, Peng; Yang, Haiyan; Kim, Hyunjung; Tong, Meiping |
| 2013 | Influence of sulfate on the transport of bacteria in quartz sand | Shen, Xiufang; Han, Peng; Yang, Haiyan; Kim, Hyunjung; Tong, Meiping |
| 2-Nov-2023 | Loncastuximab Tesirine Demonstrated Substantial Single-Agent Efficacy and Manageable Safety Profile in Heavily Pretreated Chinese Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) | Lin, Ningjing; Sun, Xiuhua; Zhou, Hui; Zou, Liqun; Zhou, Keshu; Liu, Lihong; Yang, Haiyan; Hu, Kai; Cai, Qingqing; Liu, Yao; Jin, Jie; Zhang, Liling; Li, Wenyu; Guo, Ye; Yang, Wei; Luo, Feng; Li, Yanyan; Zhang, Mengqi; Lu, Feinan; Song, Yuqin; Zhu, Jun |
| 2023 | Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 15-Nov-2022 | Long-Term Outcomes of Second-Line Vs Later-Line Zanubrutinib Treatment in Patients with Relapsed/Refractory MCL: An Updated Pooled Analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael L.; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 2016 | Management of ST-segment elevation myocardial infarction in predominantly rural central China A retrospective observational study | Zhang, You; Yang, Shuyan; Liu, Xinyun; Li, Muwei; Zhang, Weidong; Yang, Haiyan; Hu, Dayi; Gao, Chuanyu; Duan, Guangcai |
| 4-Nov-2021 | A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China | Liu, Weiping; Zhao, Donglu; Liu, Ting; Niu, Ting; Song, Yongping; Xu, Wei; Jin, Jie; Cai, Qingqing; Huang, Huiqiang; Li, Zhiming; Hou, Ming; Zhang, Huilai; Zhou, Jianfeng; Hu, Jianda; Shen, Jianzhen; Shi, Yuankai; Yang, Yu; Zhang, Liling; Zhao, Weili; Ding, Kaiyang; Qiu, Lugui; Tan, Huo; Zhang, Zhihui; Liu, Lihong; Wang, Jinghua; Xu, Bing; Zhou, Hui; Gao, Guangxun; Xue, Hongwei; Bai, Ou; Feng, Ru; Huang, Xiaobing; Yang, Haiyan; Yan, Xiaojing; Zeng, Qingshu; Liu, Peng; Li, Wenyu; Mao, Min; Su, Hang; Wang, Xin; Xu, Jingyan; Zhou, Daobin; Zhang, Hongyu; Ma, Jun; Shen, Zhixiang; Zhu, Jun |
| 2-Nov-2023 | A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas | Song, Yuqin; Li, Zengjun; Wu, Huijing; Jin, Jie; Zhou, Hui; Zhou, Keshu; Zhang, Liling; Peng, Zhigang; Zhang, Zhiye; Cen, Hong; Jia, Youchao; Shuang, Yuerong; Li, Zhiming; Yang, Haiyan; Zou, Liqun; Li, Zhifeng; Zhang, Zhihui; Li, Junmin; Cao, Junning; Qiu, Lugui; Wu, Shaojie; Gong, Tiejun; Xu, Xiaohong; Wang, Zhen; Zhu, Jun |
| 2023 | Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study | Deng, Lijuan; Li, Zhiming; Zhang, Huilai; Huang, Haiwen; Hu, Jianda; Liu, Lihong; Liu, Ting; Jin, Jie; Zhu, Zunmin; Li, Wenyu; Huang, Zhenqian; Huang, Wenrong; Zhou, Keshu; Yang, Haiyan; Zhang, Mingzhi; Ding, Kaiyang; Zhou, Hui; Hu, Yu; Shuang, Yuerong; Cao, Junning; Gao, Sujun; Li, Dengju; Sun, Zimin; Zhang, Qingyuan; Yi, Shuhua; Ji, Chunyan; Zhang, Liansheng; Hou, Cheng; Du, Yue; Wang, Weige; Zhao, Renbin; Song, Yuqin; Zhu, Jun |
| 2018 | Pattern of Rituximab Use Among Patients with B-Cell Non-Hodgkin's Lymphoma: A Report from China Lymphoma Patient Registry (CLAP) | Yang, Haiyan; Song, Yuqin; Zhang, Huilai; Liu, Aichun; Cen, Xinan; Zhu, Jun; Wen, Yi |
| 2-Nov-2023 | Phase 2 Search Study:XPO1 Inhibitor (ATG-010) Monotherapy in Heavily Pretreated Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Song, Yuqin; Cai, Qingqing; Zhang, Qingyuan; Sun, Xiuhua; Yang, Haiyan; Yao, Zhihua; Zou, Liqun; Zhang, Liling; Cao, Junning; Wang, Tingyu; Li, Lanfang; Liu, Yao; Jing, Hongmei; Gao, Sujun; Ding, Kaiyang; Liu, Bingshan; Zhao, Jun; Zhu, Jun |
| 16-Apr-2020 | A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma | Shi, Yuankai; Song, Yongping; Qin, Yan; Zhang, Qingyuan; Han, Xiaohong; Hong, Xiaonan; Wang, Dong; Li, Wei; Zhang, Yang; Feng, Jifeng; Yang, Jianmin; Zhang, Huilai; Jin, Chuan; Yang, Yu; Hu, Jianda; Wang, Zhao; Jin, Zhengming; Su, Hang; Wang, Huaqing; Yang, Haiyan; Fu, Weijun; Zhang, Mingzhi; Zhang, Xiaohong; Chen, Yun; Ke, Xiaoyan; Liu, Li; Yu, Ding; Chen, Guo'an; Wang, Xiuli; Jin, Jie; Sun, Tao; Du, Xin; Cheng, Ying; Yi, Pingyong; Zhao, Xielan; Ma, Chaoming; Cheng, Jiancheng; Chai, Katherine; Luk, Alvin; Liu, Eugene; Zhang, Xin |
| 7-Jun-2021 | A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma | Cui, Jiujie; Yang, Haiyan; Liu, Jue; Chen, Donghui; Hu, Jiong; Zhang, Haiyan; Wang, Yu; Han, Ting; Mao, Tiebo; Jiao, Feng; Biskup, Ewelina; Pan, Yaotian; Liu, Min; Wang, Liwei |
| Jul-2024 | Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors | Song, Yuqin; Cao, Junning; Zhang, Qingyuan; Li, Caixia; Qiu, Lugui; Qi, Junyuan; Zhang, Huilai; Li, Wenyu; Liu, Lihong; Jing, Hongmei; Zhou, Keshu; Zhang, Weijing; Zhang, Liling; Li, Daqi; Zou, Liqun; Yang, Haiyan; Qian, Wenbin; Zhou, Hui; Hu, Jianda; Yin, Hongyan; Fu, Sisi; Fan, Songhua; Xu, Qian; Wang, Jian; Jia, Xiaoyun; Dai, Guangxiu; Su, Weiguo; Zhu, Jun |
| 20-May-2020 | PhaseI/IIa Study evaluating the safety, efficacy of K-001 in advanced pancreatic ductal adenocarcinoma. | Cui, Jiujie; Yang, Haiyan; Chen, Donghui; Hu, Jiong; Zhang, Haiyan; Jiao, Feng; Liu, Min; Liu, Jue; Wang, Li-Wei |
